rs1934636

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_172362.3(KCNH1):​c.2112+18797G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.826 in 152,178 control chromosomes in the GnomAD database, including 51,991 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.83 ( 51991 hom., cov: 32)

Consequence

KCNH1
NM_172362.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.204

Publications

1 publications found
Variant links:
Genes affected
KCNH1 (HGNC:6250): (potassium voltage-gated channel subfamily H member 1) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily H. This member is a pore-forming (alpha) subunit of a voltage-gated non-inactivating delayed rectifier potassium channel. It is activated at the onset of myoblast differentiation. The gene is highly expressed in brain and in myoblasts. Overexpression of the gene may confer a growth advantage to cancer cells and favor tumor cell proliferation. Alternative splicing of this gene results in two transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
KCNH1 Gene-Disease associations (from GenCC):
  • KCNH1 associated disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Illumina
  • Temple-Baraitser syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • Zimmermann-Laband syndrome 1
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Zimmermann-Laband syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.86 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNH1NM_172362.3 linkc.2112+18797G>T intron_variant Intron 10 of 10 ENST00000271751.10 NP_758872.1 O95259-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNH1ENST00000271751.10 linkc.2112+18797G>T intron_variant Intron 10 of 10 2 NM_172362.3 ENSP00000271751.4 O95259-1

Frequencies

GnomAD3 genomes
AF:
0.826
AC:
125642
AN:
152060
Hom.:
51945
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.845
Gnomad AMI
AF:
0.868
Gnomad AMR
AF:
0.820
Gnomad ASJ
AF:
0.848
Gnomad EAS
AF:
0.881
Gnomad SAS
AF:
0.877
Gnomad FIN
AF:
0.773
Gnomad MID
AF:
0.829
Gnomad NFE
AF:
0.815
Gnomad OTH
AF:
0.823
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.826
AC:
125745
AN:
152178
Hom.:
51991
Cov.:
32
AF XY:
0.826
AC XY:
61444
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.845
AC:
35071
AN:
41512
American (AMR)
AF:
0.820
AC:
12544
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.848
AC:
2944
AN:
3472
East Asian (EAS)
AF:
0.881
AC:
4565
AN:
5182
South Asian (SAS)
AF:
0.877
AC:
4230
AN:
4822
European-Finnish (FIN)
AF:
0.773
AC:
8189
AN:
10592
Middle Eastern (MID)
AF:
0.820
AC:
241
AN:
294
European-Non Finnish (NFE)
AF:
0.815
AC:
55438
AN:
67996
Other (OTH)
AF:
0.822
AC:
1731
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1151
2303
3454
4606
5757
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
888
1776
2664
3552
4440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.822
Hom.:
80190
Bravo
AF:
0.831
Asia WGS
AF:
0.855
AC:
2973
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.2
DANN
Benign
0.65
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1934636; hg19: chr1-210929893; API